APOBEC3B and neoplasm: As a mimic of the clinical scenario in which a patient’s own tumor cells would be used as the platform for the APOBEC3B-modified vaccine, Mel888-APOBEC3BACTIVE or Mel888-GFP cells were used to educate donor T cells against unmodified Mel888 cells.